Beam Therapeutics Inc. (BEAM) Operating margin 2019–2025
Beam Therapeutics Inc. (BEAM) operating margin by fiscal year — reported operating income divided by reported revenue.
-274.6%FY2025 · since FY2019: -417522.2% → -274.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -274.6% | +379.7 pp |
| FY2024 | -654.3% | -607.5 pp |
| FY2023 | -46.7% | +508.9 pp |
| FY2022 | -555.6% | +201.4 pp |
| FY2021 | -757.0% | +552409.7 pp |
| FY2020 | -553166.7% | -135644.4 pp |
| FY2019 | -417522.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice